Deciphering the molecular mechanism by which the ubiquitin proteasomal system regulates MAST1 protein turnover might be an effective way to advance MAST1-based therapy for cancer patients and overcome cisplatin-resistance. The gene discussed is MAST1; the disease is cancer.